CSE/NIRV.X (CSE/NIRV.X)

Canadian Securities Exchange: CSE/NIRV.X · CAD

CA$0.05

+0.00 (0.0%)· Recorded snapshot

Market cap	1.1M
Net income (ttm)	-358.6K
EPS (ttm)	-CA$0.02
Shares out	22.9M
Volume	1,000
Beta	-0.93

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -358.6K
EPS (ttm): -CA$0.02
Market cap: 1.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/NIRV.X indicators

Market & fundamental data

Available fields

124

Groups with data

Currency

CAD

Showing 124 of 124 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-30
Employees change	0
Employees growth	0%
Enterprise value	CAD 1.3M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-01-31
First seen	2026-05-10
Fiscal year end	April
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	CA6546522054
Last refreshed	2026-10-30
Last stock split date	2025-03-24
Last stock split type	Reverse
Market cap	CAD 1.1M
Next earnings date	2026-12-30
Price	CAD 0.05
Price currency	CAD
SIC code	2834
Stock price date	2026-09-04
Symbol	cse/NIRV.X
Website	https://nirvanalifescience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-31.29%
FCF / EV yield	-68.68%
FCF yield	-76.81%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-1,018.39%
ROCE	53.3%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -332,059
EPS	CAD -0.02
FCF per share	CAD -0.04
Financing cash flow	CAD 1M
Free cash flow	CAD -880,322
Free cash flow minus SBC	CAD -895,445
Net borrowing	CAD 56,046
Net cash flow	CAD 8,789
Net income	CAD -358,633
Operating cash flow minus SBC	CAD -895,445
Operating income	CAD -332,059
Stock-based compensation	CAD 15,123

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.03
Interest coverage	-166.03
Long-term assets	CAD 0
Long-term liabilities	CAD 86,274
Net cash (debt)	CAD -140,826
Net cash / market cap	-12.29%
Piotroski F-Score	1
Shareholders' equity	CAD -709,221
Tangible book value	CAD -703,921
Tangible book value per share	CAD -0.03
Total assets	CAD 20,319
Total cash	CAD 1,347
Total debt	CAD 142,173
Total liabilities	CAD 729,540
WACC	-0.63%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 20,319
Current liabilities	CAD 643,266
Current ratio	0.03
Net working capital	CAD -482,121
Quick ratio	0.03
Working capital	CAD -622,947

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	38.43%
Shareholder yield	38.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.31
1D price change	0%
1Y price change	-41.18%
1Y return CAGR	-41.2%
1Y total return	-41.18%
20-day SMA	CAD 0.05
200-day SMA	CAD 0.44
3M price change	25%
3M total return	25%
3Y price change	-93.75%
3Y return CAGR	-60.31%
3Y total return	-93.75%
50-day SMA	CAD 0.11
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.14
52-week high date	2025-10-10
52-week low	CAD 0.01
52-week low date	2026-02-26
6M price change	900%
6M total return	900%
All-time high	CAD 9.50
All-time high date	2022-03-22
All-time low	CAD 0.01
All-time low date	2026-02-25
Average true range (ATR)	CAD 0.02
Average volume	6.8K
Beta (1Y)	-1.98
Beta (2Y)	-2.87
Beta (5Y)	-0.93
Change from 52-week high	-64.29%
Change from 52-week low	900%
Change from all-time high	-99.47%
Change from all-time low	900%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 50
High price	CAD 0.05
Low price	CAD 0.05
Monthly RSI	32.2
Open price	CAD 0.05
Previous close	CAD 0.05
Price vs 150-day SMA	-83.73%
Price vs 20-day SMA	7.99%
Price vs 200-day SMA	-88.73%
Price vs 50-day SMA	-54.21%
Relative volume	0.15
RSI	46.78
Sharpe ratio	1.88
Sortino ratio	6.88
Volume	1K
Weekly RSI	40.94
YTD price change	-33.33%
YTD total return	-33.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16.3M
Shares change (QoQ)	-0.48%
Shares change (YoY)	-38.43%
Shares held by insiders	9.78%
Shares outstanding	22.9M

Deeper analysis on CSE/NIRV.X

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/NIRV.X report

Is a complete CSE/NIRV.X research report available?

No complete published report is available for cse/NIRV.X (CSE/NIRV.X) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/NIRV.X (CSE/NIRV.X)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/NIRV.X

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/NIRV.X indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/NIRV.X

Frequently asked questions